The Coalition for Access to Prenatal Screening
The Coalition for Access to Prenatal Screening (CAPS) is a collaborative alliance of five leading genetic testing companies in the U.S. that seeks to improve access to state-of-the-art prenatal screening using cell-free DNA (cfDNA)-based noninvasive prenatal screening (NIPS) that is easily accessible to all pregnant women who choose to pursue aneuploidy screening, regardless of their risk factors, income, age or geographic location.
Be Heard by Health Plans.
Would you like to advocate for insurance coverage of
cell-free DNA screening for fetal aneuploidies?
If you’re a medical practitioner
If you’re a patient